Render Target: STATIC
Render Timestamp: 2024-12-03T11:01:49.126Z
Commit: cd2fae6ca3f811b1ddb1df24ac291ed56d5d501b
XML generation date: 2024-11-18 16:03:18.110
Product last modified at: 2024-11-20T09:00:12.981Z
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

AKAP12 (F4H6G) Rabbit mAb #48427

Filter:
  • WB
  • IF

    Supporting Data

    REACTIVITY H M R
    SENSITIVITY Endogenous
    MW (kDa) 300
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IF-Immunofluorescence 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • R-Rat 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunofluorescence (Immunocytochemistry) 1:800 - 1:1600

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    AKAP12 (F4H6G) Rabbit mAb recognizes endogenous levels of total AKAP12 protein. Based on the sequence of the peptide antigen, this antibody is expected to detect all isoforms of human AKAP12 protein. Reactivity for immunofluorescence is human only.

    Species Reactivity:

    Human, Mouse, Rat

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Lys407 of human AKAP12 protein.

    Background

    A-kinase anchoring protein 12 (AKAP12), also known as Gravin, is a scaffold protein that regulates intracellular signaling by sequestering signaling molecules in subcellular compartments as protein complexes. AKAP12 regulates protein kinase A (PKA) and protein kinase C (PKC)-dependent signaling and controls cell cycle progression, cytoskeletal dynamics, vascular development, glial function, and angiogenesis. AKAP12 expression is correlated with chronic liver diseases (CLDs), inflammatory diseases, and several human cancers (1,2). AKAP12 is a potential therapeutic target for the treatment of esophageal squamous cell carcinoma (ESCC) and colorectal cancer (3,4), and may serve as a biomarker for anti-VEGF therapy-resistant cancer, where its expression is upregulated (5).

    AKAP12 is highly expressed in heart, regulates desensitization and recycling of β2-adrenergic-receptor (β2AR), and has been implicated in cardiovascular disease initiation and progression (6). Increased expression of AKAP12 in heart is associated with accelerated cardiac dysfunction (7).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.